Table 2.
Outcomes | Outcome Prevalence by Presence of Postoperative AKI Stage 1 or Worse versus No AKI, n/total (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
3 Mo | 12 Mo | 24 Mo | 36 Mo | 48 Mo | ||||||
AKI | No AKI | AKI | No AKI | AKI | No AKI | AKI | No AKI | AKI | No AKI | |
CKD | 12/49 (24) | 10/60 (17) | 15/51 (29) | 17/59 (29) | 10/48 (21) | 14/56 (25) | 8/43 (19) | 10/55 (18) | 7/42 (17) | 9/54 (17) |
Low eGFRa | 2/51 (4) | 4/61 (7) | 2/53 (4) | 5/58 (9) | 1/49 (2) | 3/56 (5) | 1/45 (2) | 3/54 (6) | 0/43 (0) | 5/53 (9) |
High UACRa | 11/54 (20) | 7/65 (11) | 13/52 (25) | 12/62 (19) | 9/52 (17) | 12/58 (21) | 8/47 (17) | 7/57 (12) | 7/45 (16) | 4/56 (7) |
Systolic and/or diastolic hypertension | 19/45 (42)b | 14/64 (22) | 22/45 (49)c | 10/57 (18) | 15/47 (32) | 13/59 (22) | 9/44 (20) | 12/56 (21) | 11/46 (24) | 12/57 (21) |
Hypertension and/or CKDa | 29/46 (63)b | 22/59 (37) | 27/46 (59) | 23/58 (40) | 21/44 (48) | 24/56 (43) | 15/40 (38) | 20/54 (37) | 16/42 (38) | 18/55 (33) |
Outcomes | Outcome Prevalence by Presence of Postoperative AKI Stage 2 or Worse versus No AKI or Stage 1 AKI, n/total (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
3 Mo | 12 Mo | 24 Mo | 36 Mo | 48 Mo | ||||||
≥Stage 2 AKI | No AKI or Stage 1 | ≥Stage 2 AKI | No AKI or Stage 1 | ≥Stage 2 AKI | No AKI or Stage 1 | ≥Stage 2 AKI | No AKI or Stage 1 | ≥Stage 2 AKI | No AKI or Stage 1 | |
CKD | 5/23 (22) | 17/86 (20) | 8/24 (33) | 24/86 (28) | 2/23 (9) | 22/81 (27) | 5/17 (29) | 13/81 (16) | 3/18 (17) | 13/78 (17) |
Low eGFRa | 2/23 (9) | 4/89 (5) | 1/26 (4) | 6/85 (7) | 0/24 (0) | 4/81 (5) | 1/19 (5) | 3/80 (4) | 0/19 (0) | 5/77 (6) |
High UACRa | 4/27 (15) | 14/92 (15) | 7/25 (28) | 18/89 (20) | 2/25 (8) | 19/85 (22) | 5/20 (25) | 10/84 (12) | 3/20 (15) | 8/81 (10) |
Systolic and/or diastolic hypertension | 11/22b (50) | 22/87 (25) | 14/22c (64) | 18/80 (23) | 8/22 (36) | 20/84 (24) | 5/20 (25) | 16/80 (20) | 6/21 (29) | 17/82 (21) |
Hypertension and/or CKDa | 14/21 (67) | 37/84 (44) | 15/22b (68) | 35/82 (43) | 8/20 (40) | 37/80 (46) | 9/17 (53) | 26/77 (34) | 8/18 (44) | 26/79 (33) |
CKD defined as low GFR, estimated using serum creatinine or high UACR. UACR, urinary albumin-creatinine ratio.
Note that composite outcome participant numbers will differ from the numbers for the components of the composite outcomes (e.g., CKD total, versus totals for low eGFR and high UACR).
P<0.05
P<0.005, for difference in proportion with outcome between AKI and non-AKI groups or between stage 2 or worse AKI versus no AKI/stage 1 groups.